CURRENT PERSPECTIVES ON THE SIGNIFICANCE AND INTERPRETATION OF FACTOR-VIII AND FACTOR-IX INHIBITORS - PANEL DISCUSSION

被引：0
|
作者：
LUSHER, J
BRIET, E
KASPER, C
HOYER, L
HOOTS, K
HAY, C
GRUPPO, R
ROBERTS, H
RICKLES, F
MARCINIAK, E
ALEDORT, L
PRESTON, E
KISKER, T
KIM, H
LAURIAN, Y
机构：
[1] LEIDEN UNIV HOSP, 2333 AA LEIDEN, NETHERLANDS
[2] ORTHOPED HOSP, LOS ANGELES, CA 90007 USA
[3] AMER RED CROSS, HOLLAND LAB, BETHESDA, MD USA
[4] ROYAL LIVERPOOL HOSP, LIVERPOOL L7 8XP, MERSEYSIDE, ENGLAND
[5] CHILDRENS HOSP MED CTR, CINCINNATI, OH 45229 USA
[6] UNIV N CAROLINA, CHAPEL HILL, NC 27514 USA
[7] MT SINAI MED CTR, NEW YORK, NY 10029 USA
来源：
BLOOD COAGULATION & FIBRINOLYSIS | 1991年 / 2卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：63 / 74
页数：12
相关论文
共 50 条
  • [41] EFFECT OF STANOZOLOL ON FACTOR-VIII AND FACTOR-IX AND SERUM AMINOTRANSFERASES IN HEMOPHILIA
    GREER, IA
    GREAVES, M
    MADHOK, R
    MCLOUGHLIN, K
    PORTER, N
    LOWE, GDO
    PRESTON, FE
    FORBES, CD
    THROMBOSIS AND HAEMOSTASIS, 1985, 53 (03) : 386 - 389
  • [42] HEPATITIS-C AND PASTEURIZED FACTOR-VIII AND FACTOR-IX CONCENTRATES
    KREUZ, W
    KLARMANN, D
    AUBERGER, K
    AUERSWALD, G
    RABENAU, H
    GURTLER, L
    ROGGENDORF, M
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1459 - 1459
  • [43] ORAL-ADMINISTRATION OF CONCENTRATED FACTOR-VIII OR FACTOR-IX PREPARATIONS
    SAKURAGAWA, N
    TAKAHASHI, K
    HORIKOSHI, I
    THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 124 - 124
  • [44] MODULATION OF ALLOGENEIC CYTOTOXIC ACTIVITY BY FACTOR-VIII OR FACTOR-IX CONCENTRATES
    SORIA, AG
    BOUZAS, MB
    ANSELMO, A
    RUIBALARES, BH
    HAEMATOLOGICA, 1991, 76 (01) : 33 - 37
  • [45] DOUBLE HETEROZYGOSITY IN A HEMOPHILIC FEMALE - FACTOR-VIII AND FACTOR-IX DEFICIENCY
    MILLER, CH
    VORSANGER, GV
    DIAZ, M
    ALEDORT, LM
    AMERICAN JOURNAL OF HUMAN GENETICS, 1982, 34 (06) : A102 - A102
  • [46] LABORATORY TESTS FOR FACTOR-VIII INHIBITORS, THEIR VARIATION, SIGNIFICANCE AND INTERPRETATION
    KASPER, CK
    BLOOD COAGULATION & FIBRINOLYSIS, 1991, 2 : 7 - 10
  • [47] PERSPECTIVES ON THE USE OF FACTOR-IX COMPLEX CONCENTRATES IN THE TREATMENT OF BLEEDING IN PERSONS WITH ACQUIRED FACTOR-VIII INHIBITION
    LUSHER, JM
    AMERICAN JOURNAL OF MEDICINE, 1991, 91 : S30 - S34
  • [48] INEFFECTIVENESS OF CERTAIN COMMERCIAL PROTHROMBIN COMPLEX CONCENTRATES IN TREATMENT OF PATIENTS WITH INHIBITORS OF FACTOR-VIII AND FACTOR-IX
    PENNER, JA
    ABILDGAARD, CF
    NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (10): : 565 - 566
  • [49] VONWILLEBRAND-FACTOR MODULATES THE ACTIVATION AND PROTEOLYSIS OF FACTOR-VIII BY ACTIVATED FACTOR-IX
    RICK, ME
    KRIZEK, DM
    CLINICAL RESEARCH, 1989, 37 (02): : A386 - A386
  • [50] INFLUENCE OF FACTOR-VIII LIGHT CHAIN AND FACTOR-VIII HEAVY-CHAIN ON BINDING OF FACTOR-IX AND FACTOR-X TO PLATELETS
    MUNTEAN, W
    LESCHNIK, B
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 941 - 941
12345